Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001837289 | SCV002097811 | uncertain significance | Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities | 2021-02-10 | criteria provided, single submitter | clinical testing | The c.644G>T, p.Gly215Val missense variant identified in NARS1 has not been reported in the literature. This variant is absent in the gnomAD v3.1database, indicating this is a rare allele and in silico analysis predicts deleterious effect [PMID:27268795]. The position is strongly conserved (GERP++ = 6.17). Based on the available evidence, the missense variant c.644G>T, p.Gly215Val in the NARS1 gene is classified as a Variant of Uncertain Significance. |